Hls Therapeutics
(OTC) HLTRF
Hls Therapeutics Financials at a Glance
Market Cap
$105.14M
Revenue (TTM)
$55.73M
Net Income (TTM)
$12.45M
EPS (TTM)
$-0.39
P/E Ratio
-8.54
Dividend
$0.00
Beta (Volatility)
0.01 (Low)
Dividend
$0.00
Beta (Volatility)
0.01 (Low)
Price
$3.36
Volume
100
Open
$3.36
Price
$3.36
Volume
100
Open
$3.36
Previous Close
$3.36
Daily Range
$3.36 - $3.36
52-Week Range
$2.96 - $4.02
Dividend
$0.00
Beta (Volatility)
0.01 (Low)
Price
$3.36
Volume
100
Open
$3.36
Previous Close
$3.36
Daily Range
$3.36 - $3.36
52-Week Range
$2.96 - $4.02
HLTRF News
HLTRF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Hls Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
85
CEO
Craig Millian, MBA
Website
www.hlstherapeutics.comHeadquarters
Etobicoke, ON M9W 6L2, CA
HLTRF Financials
Key Financial Metrics (TTM)
Gross Margin
72%
Operating Margin
-7%
Net Income Margin
-22%
Return on Equity
-19%
Return on Capital
-4%
Return on Assets
-9%
Earnings Yield
-11.71%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$105.14M
Shares Outstanding
31.27M
Volume
100
Short Interest
0.00%
Avg. Volume
17.267
Financials (TTM)
Gross Profit
$24.01M
Operating Income
$4.18M
EBITDA
$18.02M
Operating Cash Flow
$16.02M
Capital Expenditure
$208.59K
Free Cash Flow
$15.81M
Cash & ST Invst.
$11.70M
Total Debt
$49.73M
Hls Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$15.43M
-0.7%
Gross Profit
$7.20M
-44.0%
Gross Margin
46.65%
N/A
Market Cap
$105.14M
N/A
Market Cap/Employee
$1.14M
N/A
Employees
92
N/A
Net Income
$1.36M
+55.2%
EBITDA
$5.79M
+20.7%
Quarterly Fundamentals
Net Cash
$38.03M
+22.4%
Accounts Receivable
$7.85M
+4.3%
Inventory
$8.12M
-10.3%
Long Term Debt
$44.92M
-26.6%
Short Term Debt
$4.81M
-9.0%
Return on Assets
-9.07%
N/A
Return on Invested Capital
-3.69%
N/A
Free Cash Flow
$6.41M
+100.8%
Operating Cash Flow
$6.44M
+101.0%